SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-22-010902
Filing Date
2022-07-22
Accepted
2022-07-21 21:47:07
Documents
8
Period of Report
2022-08-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A tmb-20220831xdef14a.htm DEF 14A 174917
2 GRAPHIC tmb-20220831xdef14a005.jpg GRAPHIC 5458
3 GRAPHIC tmb-20220831xdef14a013.jpg GRAPHIC 134803
4 GRAPHIC tmb-20220831xdef14a015.jpg GRAPHIC 139381
5 GRAPHIC tmb-20220831xdef14a014.jpg GRAPHIC 171969
6 GRAPHIC tmb-20220831xdef14a008.jpg GRAPHIC 3409
7 GRAPHIC tmb-20220831xdef14a012.jpg GRAPHIC 123839
8 GRAPHIC tmb-20220831xdef14a006.jpg GRAPHIC 3228
  Complete submission text file 0001558370-22-010902.txt   978737
Mailing Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660
Business Address 1111 MAIN STREET, SUITE 660 VANCOUVER WA 98660 360-980-8524
CytoDyn Inc. (Filer) CIK: 0001175680 (see all company filings)

IRS No.: 753056237 | State of Incorp.: DE | Fiscal Year End: 0531
Type: DEF 14A | Act: 34 | File No.: 000-49908 | Film No.: 221098340
SIC: 2834 Pharmaceutical Preparations